Terns Pharmaceuticals Reports Second Quarter 2022 Financial
TERN-701 (allosteric BCR-ABL inhibitor) advances into Phase 1 trial for CML in ChinaIND-enabling activities for TERN-601 (GLP-1R agonist) remain on track;...
Source: globenewswire.com
Terns Board News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Terns Board. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Terns Board Today - Breaking & Trending Today
Terns Pharmaceuticals : Announces Appointment of Radhika Tripuraneni, M.D., M.P.H. to Board of Directors - Form 8-K
Terns Pharmaceuticals, Inc. , a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases such as non-alcoholic steatohepatitis...
Source: marketscreener.com